Connect with us

News

This week in health tech: January 9, 2022

Published

on

In today’s Health Tech World roundup, we bring you research updates, investment news and interviews from around the world.

This week, Elizabeth Holmes, the founder of blood-testing startup Theranos, was found guilty on four of 11 charges of fraud. Researchers developed a rapid prostate cancer screening kit that could provide early warning to populations with a higher incidence of prostate cancer. And digital healthcare company Babylon Health has acquired US-based consumer health engagement company​ Higi Health.

Elizabeth Holmes verdict: Former Theranos CEO convicted of fraud

Elizabeth Holmes, the founder of blood-testing startup Theranos has been found guilty on four of 11 charges of fraud. A jury convicted her on two counts of wire fraud and two counts of conspiracy to commit fraud after seven days of deliberation following a three-month trial.

Rapid prostate cancer test could help reach underserved men

Researchers from Cornell University have developed a portable, rapid prostate cancer screening kit that could provide early warning to populations with a higher incidence of prostate cancer.

Interview: Helping cancer patients access potentially lifesaving testing and treatment

More than 60 per cent of cancer patients are missing out on potentially life-saving treatments because their physicians aren’t able to provide them with all the information they need.

Babylon Health acquires health engagement company Higi Health

Digital healthcare company Babylon Health has acquired US-based consumer health engagement company​ Higi Health, which offers biometric self-screening health stations located within five miles of 73 per cent of the population.

Paving the way towards future development and innovation in NHS healthcare

The Academic Health Science Network for the North East and North Cumbria is paving the way towards future development and innovation in NHS healthcare.

Biomarkers licensing deal could make early cancer detection more accurate

The agreement will give molecular genetics diagnostic company Mainz Biomed access to a portfolio of novel mRNA biomarkers for potential future integration into Mainz’s detection test for colorectal cancer.

UK health tech pioneers reunite at Arab Health 2022

The UK Pavilion is heading back to Arab Health 2022, one of the world’s leading platforms for international trade in the healthcare sector, representing a huge opportunity for HealthTech companies to showcase the very best of British.

Hospify platform to close following suspension of Data Protection Act

Hospify will close its communications platform at the end of January following the government’s decision to suspend relevant terms of the UK 2018 Data Protection Act.

Call for digital triage system to tackle NHS waiting list backlog

Remote consultation solutions provider eConsult said the UK government needs to invest in a digital triage system to get the right patients to the right point of care, unclog the healthcare system and increase efficiency.

Extending cervical cancer screening wait ‘could cost lives’, campaigners warn

The period between routine cervical cancer screenings has been extended from every three years to every five years in Wales for women and people with a cervix aged 25 to 49.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Health tech alerts



Sign up for HT World updates

Copyright © 2021 Aspect Publishing Ltd.